Pan-Coronavirus CRISPR-CasRx Effector System Significantly Reduces Viable Titer in HCoV-OC43, HCoV-229E, and SARS-CoV-2

Cathryn M. Mayes, Joshua L. Santarpia

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pan-Coronavirus CRISPR-CasRx Effector System Significantly Reduces Viable Titer in HCoV-OC43, HCoV-229E, and SARS-CoV-2'. Together they form a unique fingerprint.

Medicine & Life Sciences